AI reads heart scans to guide treatment in 20,000 patients

NCT ID NCT06376851

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This registry is collecting data from 20,000 people with coronary artery disease to see if an AI tool that analyzes CT scans of the heart can help doctors make better treatment decisions. The AI measures the amount and type of plaque in the arteries. Researchers will compare how medical management changes after doctors get the AI results versus standard CT scans alone. This is an observational study, so no new treatment is being tested.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

AI-enabled quantitative coronary plaque analysis (AI-QCPA)

What this could lead to

If successful, this could show that AI analysis of CT scans helps doctors choose better treatments for heart disease patients.

What could go wrong

This is an observational registry, not a treatment trial, so it won't prove that AI analysis directly improves health outcomes. Results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Moses Cone Memorial Hospital

    Greensboro, North Carolina, 27401, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.